Tonix Pharmaceuticals Holding Corp. SEC filings TNXP
Tonix Pharmaceuticals Holding Corp. has 1,000 filings in SEC EDGAR's recent list, going back to May 2, 2017. Its latest annual report, Form ARS, was filed on Mar 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (results of operations, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Mar 13, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Mar 18, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 18, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 15, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Mar 29, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 13, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 14, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 15, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 24, 2020 | Dec 31, 2019 |
| 10-K/A | Amended annual report | Mar 18, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 18, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 9, 2018 | Dec 31, 2017 |
| 10-K/A | Amended annual report | Sep 1, 2017 | Dec 31, 2016 |
Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TNXP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Berkeley Heights, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1430306
- Former names
- TAMANDARE EXPLORATIONS INC. (until Oct 17, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.